poliomyelitis

Documents about poliomyelitis

• Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Poliorix™ Vaccine#172408ClinicalTrials.gov
• Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh#303577ClinicalTrials.gov
• Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation#146277ClinicalTrials.gov
• Safety and Reactogenicity of GSK Biologicals' Inactivated Poliomyelitis Vaccine (IPV) (Poliorix) in Infants#226331ClinicalTrials.gov
• Safety evaluation of inactivated poliomyelitis vaccine.#9920PubMed
• Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' IPV Vaccine (PoliorixTM) in Toddlers#907405ClinicalTrials.gov
• The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains (IPV)#136395ClinicalTrials.gov
• Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers#846900ClinicalTrials.gov
• The Immunogenicity and Safety of Live Attenuated Poliomyelitis Vaccine (Human Diploid Cell)#674788ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults#148565ClinicalTrials.gov
• A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants#874610ClinicalTrials.gov
• The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)#162549ClinicalTrials.gov
• Effect of Lactoferrin on Polio Seroconversion#18679ClinicalTrials.gov
• Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older#854080ClinicalTrials.gov
• Persistence of IPV Immunity#261360ClinicalTrials.gov
• Poliomyelitis eradication in the Eastern Mediterranean Region: progress report 2010#216371WHO IRIS
• Acute flaccid paralysis (excluding poliomyelitis)～diagnosis and treatment～#69572J-STAGE (Japan)
• IPV Clinical Trial - The Gambia#332797ClinicalTrials.gov
• Immunogenicity of Intramuscular and Intradermal IPV#387222ClinicalTrials.gov
• Report on the second meeting of the regional commission for certification of poliomyelitis eradication, Alexandria, Egypt, 2-3 December 1997#293659WHO IRIS
• Clinical Trial of Novel OPV2 Vaccine#230468ClinicalTrials.gov
• Duration of IPV Priming and Antibody Decay#332806ClinicalTrials.gov
• Immunogenicity of Inactivated and Live Polio Vaccines#674780ClinicalTrials.gov
• Safety of Imovax Polio in Chinese Infants and Children#127671ClinicalTrials.gov
• Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study#181595ClinicalTrials.gov
• Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine#314382ClinicalTrials.gov
• Lot-consistency Clinical Trial of Sabin Strain Inactivated Polio Vaccine#356517ClinicalTrials.gov
• Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers#451524ClinicalTrials.gov
• Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules#432923ClinicalTrials.gov
• IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults#633760ClinicalTrials.gov
• A Study of the Safety of IMOVAX Polio™ in China#835396ClinicalTrials.gov
• Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)#832924ClinicalTrials.gov
• Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers#844616ClinicalTrials.gov
• Phase III Clinical Trial of Sabin Strain Inactivated Poliovirus Vaccine (Vero Cell)#143635ClinicalTrials.gov
• A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV#217102ClinicalTrials.gov
• Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine#353342ClinicalTrials.gov
• A Study to Evaluate the Safety and Immunogenicity of Novel Oral Polio Vaccine#804325ClinicalTrials.gov
• An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses#28407ClinicalTrials.gov
• Nineteenth Meeting of the WHO South-East Asia Regional Certification Commission for Poliomyelitis Eradication#432284World Health Organization
• Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine#154732ClinicalTrials.gov
• Cross-neutralization Capacity of Immune Serum From Different Dosage of Sabin Inactivated Poliovirus Vaccine Immunization#249668ClinicalTrials.gov
• Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine#290846ClinicalTrials.gov
• Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults#373652ClinicalTrials.gov
• Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine#121425ClinicalTrials.gov
• Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants#125922ClinicalTrials.gov
• A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine#245590ClinicalTrials.gov
• Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age#405208ClinicalTrials.gov
• Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib)#411262ClinicalTrials.gov
• Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine#141105ClinicalTrials.gov
• Evaluation of Persistence of Immunity in 4-year-old Children Previously Immunised With IPV-Al AJV (Picovax®)#172405ClinicalTrials.gov